Services
- Amicus
- Business Interruption & Commercial Disputes
- Class Action Defense
- Complex Litigation
- Defense & Government Contracting
- Environmental
- Federal Claims
- Financial Institutions
- Government Investigations & White Collar Defense
- Natural Resource Damages
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- Risk Mitigation & Management
- Transportation
Education
Georgetown Law (J.D., 1974) DePauw University (B.A., 1971, with distinction)Admissions
- District of Columbia
- United States Supreme Court
- United States Courts of Appeals for the Second, Third, Fourth, Sixth, Seventh, Eighth, Ninth, Tenth, Eleventh, District of Columbia, and Federal Circuits
- United States District Courts for the District of Columbia, Central District of Illinois, District of Maryland, and Eastern and Western Districts of Michigan
Accolades
- “Joe Hollingsworth’s client service and general level of service, level of sophistication, commercial awareness, and vision are all very strong. He is the best in class for service! He is outstanding.”
–Client | Chambers USA - “He is the best of the best!”
–Client | Chambers USA - “I’ve worked with hundreds of attorneys over the course of my long career. Joe and his team are at the top.”
–Client | Chambers USA - “Joe Hollingsworth is excellent on his feet.”
–Client | Chambers USA - “Joe Hollingsworth and Eric Lasker only do litigation and are highly experienced. They become experts of the issues, learning the history and background. They serve you very well in the litigation space.”
–Client | Chambers USA - “Joe Hollingsworth is a consummate trial attorney. He’s a thorough, smart and a strategic thinker. His particular niche is doing trial work for the pharma industry, and they think very highly of him. He is a top-gun to bet on for company cases.”
–Third party | Chambers USA - “He is a superb trial attorney.”
–Third party | Chambers USA - “Joe is a very savvy, experienced trial lawyer who is a go-to advisor for his clients.”
–Third party | Chambers USA
- Best Lawyers in America, 2008–2023
- Super Lawyers, Civil Litigation Defense, 2007–2024
- The National Law Journal, Top Ten Defense Wins, 2004, 2001, 1998
- AV Preeminent Lawyer – Judicial Edition by Martindale-Hubbell, 2022-2024
- AV Preeminent Lawyer by ALM Media and Martindale-Hubbell, 1996–2021
- Litigation Counsel of America, Senior Fellow
Memberships
- Atlantic Legal Foundation Board of Directors and Executive Committee
- Atlantic Coast Conference Hockey League (ACCHL) Board of Directors
- National Association of Railroad Trial Counsel (NARTC)
- Georgetown Law Board of Visitors, Former Member
Insights & Events
Hollingsworth LLP Wins 4th Circuit Appeal for Washington Commanders in Electronic Tickets Arbitration Matter
news | October 29, 2024Amicus Curie Brief on Civil RICO Filed by Hollingsworth LLP Helps Catch Supreme Court’s Attention
news | November 28, 20239/11 Special Master Ken Feinberg Praises the Firm and Founder Joe Hollingsworth
news | November 20, 2023Exclusion of Junk Science in “Bair Hugger” MDL Shows Daubert is Still Breathing
publication | January 23, 2020Joe Hollingsworth and Caroline Barker for Washington Legal Foundation's Legal Pulse
Joining List of Impressive Honorees, Longtime Firm Client, Tom Kendris of Novartis, Receives Atlantic Legal Foundation Annual Award
news | January 3, 2019Atlantic Legal Foundation is the preeminent organization fostering sound science in American jurisprudence.
Games People Play: Supreme Court Can Put a Stop to an Obvious CAFA Workaround
publication | December 27, 2018By Joe Hollingsworth and Don McMinn, for Washington Legal Foundation.
Joe Hollingsworth Serving on Steering Committee for DePauw University’s Rector Scholarship Centennial.
news | October 1, 2018The Supreme Court’s Chance to Re-Open a Preemption Door the Third Circuit Tried to Close Forever
publication | July 23, 2018By Firm founder Joe G. Hollingsworth, with Stephen A. Klein, for Washington Legal Foundation.
Hollingsworth LLP represents Monsanto in In Re:Roundup Products Liability Litigation in the Northern District of California.
Third Circuit Agrees with Hollingsworth LLP Amicus Brief in Zoloft Case, Affirming Exclusion of Causation Expert
news | June 2, 2017Hollingsworth LLP filed amicus brief in support of mobile phone makers in significant DC Court of Appeals victory.
news | November 7, 2016The Firm and the U.S. Chamber of Commerce filed a business coalition amici curiae brief supporting the mobile phone industry.
California Supreme Court Grants Petition to Review Innovator and Prior Manufacturer Liability in Pharma Litigation
news | June 10, 2016Firm client Volvo challenges the agency’s authority to regulate diesel-engine pollution across borders.
Hollingsworth LLP Files Cert Petition Challenging EPA’s Territorial Overreach.
news | December 23, 2014Georgetown Law Alumni at Hollingsworth LLP Participate at 100% in Law Firm Challenge Fundraising Effort
news | October 3, 2014"After fewer than six hours of deliberations . . . the jury in Middlesex County Superior Court handed down its 7-1 decision in the case of Beverly Meng shortly after 11 a.m. Meng's lawsuit was the second to go on trial in the New Jersey mass tort, and Novartis has won both."
And The Defense Wins: DRI’s The Voice recognizes Hollingsworth LLP in significant victory for DynCorp, International.
news | April 17, 2013The DynCorp ruling is a welcome and much needed rebuke to international activist efforts to demonize U.S. industry through unfounded legal actions arising from international operations.
Hollingsworth LLP Named for 3rd Time in 4 Years to National Law Journal‘s Midsize Hot List.
news | April 8, 2013The New Jersey Supreme Court has declined to hear a challenge to judgments for Novartis Pharmaceuticals Corp. in the first bellwether trial in consolidated litigation over claims the drugmaker's bone cancer drugs Aredia and Zometa caused jaw deterioration.
A Texas federal judge . . . ruled against a cancer patient who sued Novartis Pharmaceuticals Corp. over a jaw injury she allegedly sustained after taking Zometa, handing Novartis the latest of several wins in multidistrict litigation over the bone drug in the past several months.
DRI's The Voice
St. Louis Federal Jury Returns Verdict for Novartis in Second Zometa Defense Verdict in a Week
news | February 1, 2012Four Firm partners credited for summary judgment decision in N.D. Ga. products liability case.
news | January 11, 2012DRI's The Voice
Hollingsworth LLP Files Industry Coalition Amicus Brief in U.S. Supreme Court
news | October 13, 2011This industry coalition brief was filed on behalf of the U.S. Chamber of Commerce, American Chemistry Council, American Coatings Association, American Insurance Association, American Petroleum Institute, and National Association of Manufacturers.
Hollingsworth LLP secures major defense verdict for client Novartis in federal Aredia®/Zometa® trial.
news | May 25, 2011U.S. District Court for the Middle District of Tennessee rejects “cross-jurisdictional tolling” argument and grants Novartis summary judgment.
news | December 7, 2010Hollingsworth LLP secures key defense verdict for client Novartis in first bellwether Aredia®/Zometa® jury trial.
news | October 6, 2010Joe Hollingsworth and Eric Lasker cited by 6th Circuit in Reversal of Plaintiff Verdict in Welding Fume Litigation
news | September 8, 2010Court grants Firm client Novartis Pharmaceuticals Corporation summary judgment in case selected for first wave of trials in New Jersey Aredia® and Zometa® Mass Tort action.
news | April 12, 2010Joe Hollingsworth named to Board of Directors of the Chesapeake Legal Alliance.
news | January 25, 2010Sixth Circuit affirms grant of summary judgment in favor of Firm client Novartis in three cases based on Michigan law.
news | November 24, 2009Sixth Circuit affirms grant of summary judgment in favor of Firm client Novartis in five cases brought by non-U.S. plaintiffs.
news | November 24, 2009MDL court grants Summary Judgment in four first-wave Zometa cases; Case No. 3:08-1157 (Anderson), Case No. 3:08-1156 (Melau), Case No. 3:06-0377 (Thomas).
news | October 28, 2009MDL court grants Summary Judgment in four first-wave Zometa cases; Case No. 3:06-0659, Emerson/Crews.
news | August 17, 2009Federal Court grants summary judgment filed by Firm client Novartis Pharmaceuticals Corporation in five suits brought by foreign plaintiffs.
news | February 2, 2009Judicial Panel on Multidistrict Litigation re-transfers two cases to Aredia®/Zometa® MDL over plaintiffs’ objections.
news | December 3, 2008Federal Court grants summary judgment based on product identification to Firm client Novartis Pharmaceuticals Corporation.
news | September 29, 2008State court grants motion to dismiss for forum non conveniens to Firm client C.R. Bard, Inc.
news | August 25, 2008Joe Hollingsworth and Kate Latimer author A Framework for Toxic Tort Litigation
publication | August 15, 2008Firm client Norfolk Southern Corporation reaches favorable agreement with Avondale Mills to settle claims from Graniteville accident.
news | July 2, 2008Texas Court of Appeals Raises Causation Bar for Asbestos Plaintiffs and Their Experts
news | July 26, 2007Former lead paint manufacturers prevail in Missouri Supreme Court, with an assist from Firm client, National Paint & Coatings Association.
news | June 12, 2007In the final installment, authors Joe Hollingsworth and Eric Lasker, discuss causation opinions premised on clinical practice, and how defense counsel can effectively use Daubert to exclude causation testimony that rests upon anecdotal case reports and clinical reasoning; Michigan Defense Quarterly (April 2007)
Written by Joe Hollingsworth and Eric Lasker, the second article explains how defense counsel can assist courts in properly applying the Daubert requirements to various categories of scientific evidence often cited by plaintiffs' experts in support of general causation opinions. Michigan Defense Quarterly (January 2007).
Throwing Out Junk Science: The first article of this 3-part series discusses the legal standards for admissibility of medical causation expert testimony following the Michigan Supreme Court's adoption of the federal Daubert requirements of reliance and relevance. Michigan Defense Quarterly (October 2006) (Joe G. Hollingsworth and Eric G. Lasker).
Hollingsworth LLP Steps in as Appellate Counsel; 11th Circuit Vacates $18 million Verdict against GE
news | October 11, 2005Dodging Daubert: Suits against drug-makers are using bad science to invent causation.
publication | September 19, 2005Joe Hollingsworth and Eric Lasker Publish “Dodging Daubert” in Legal Times.
news | September 13, 2005The Case Against Differential Diagnosis: Daubert, Medical Causation Testimony, and the Scientific Method
publication | December 1, 2004Journal of Health Law (Winter 2004, Volume 37, No. 1) (Joe G. Hollingsworth and Eric G. Lasker)
Joe Hollingsworth Highlighted in The American Lawyer for Pharmaceutical Litigation Victory
news | April 8, 200411th Circuit Affirmance in Rider v. Sandoz Completes Daubert Sweep in Parlodel Litigation
news | June 24, 2002“The BEST Defense … And Then There Are Wins Without Trial,” The National Law Journal
news | March 19, 2001Conde v. Velsicol Chemical Corp.: Lessons for the Defense of Toxic Tort Cases
publication | May 3, 1995Cases
Tenth Circuit Unanimously Affirms Plaintiff’s Expert Testimony Not Scientifically Reliable
- Precedent
- Pharmaceutical & Medical Device
- February 14, 2015
Key Early Victory for Pharma Defendant Became Major Body of Daubert Case Law
- Precedent
- Pharmaceutical & Medical Device
- February 1, 2015
The Parlodel Trilogy
- Precedent
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- January 27, 2015
The Zometa Cases
- Precedent
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- Class Action Defense
- January 27, 2015
Court Dismisses $4B Claim Brought by New Mexico Against General Electric
- Precedent
- Environmental
- Products Liability & Toxic Torts
- Natural Resource Damages
- January 27, 2015
Federal Court Grants Daubert and SJ Motions to General Motors in PCB Lawsuit
- Precedent
- Environmental
- Products Liability & Toxic Torts
- October 1, 2006
Hollingsworth LLP Wins 4th Circuit Appeal for Washington Commanders in Electronic Tickets Arbitration Matter
- Case
- Complex Litigation
- October 29, 2024
Firm Client Monsanto Takes Step Forward in 11th Circuit Preemption Appeal
- Case
- Products Liability & Toxic Torts
- July 10, 2023
New Jersey Court Grants Novartis Summary Judgment in Bellwether Trial Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 6, 2014
Louisiana Federal Court Grants Summary Judgment to Novartis After Excluding Plaintiff’s Expert Witnesses
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 14, 2013
New Jersey Jury Finds No Failure to Warn in Zometa Suit
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- May 15, 2013
In Another Pharmaceutical Case, Novartis Wins Summary Judgment
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- September 19, 2012
In Major Precedent for Drugmakers, Federal Court Precludes Punitives Under New Jersey Law
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- September 5, 2012
Second Circuit Affirms Defense Verdict in Favor of Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- August 29, 2012
E.D. Missouri Grants Novartis Summary Judgment in Products Liability Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 19, 2012
Novartis Bellwether Defense Verdict Upheld on Appeal in New Jersey
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 13, 2012
Federal Court in Pharma Litigation Excludes Most of Plaintiff’s Expert’s Proffered Testimony
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- March 21, 2012
Sandoz Exits MDL After E. D. New York Finds Product Liability Claims Preempted
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- January 30, 2012
North Carolina Federal Magistrate Says New Jersey Law Should Govern Punitive Damages in Pharmaceutical Case
- Case
- Pharmaceutical & Medical Device
- December 16, 2011
New Jersey Court Says NJ Punitive Damages Law to Apply in Products Liability Suit Filed by Virginia Resident
- Case
- Pharmaceutical & Medical Device
- November 18, 2011
Sixth Circuit Affirms Summary Judgment in Three Cases for Firm Client Novartis
- Case
- Pharmaceutical & Medical Device
- August 23, 2011
Sixth Circuit Affirms Summary Judgment Based on Statutory Presumption Created by Florida Law
- Case
- Complex Litigation
- Pharmaceutical & Medical Device
- August 23, 2011
U.S. District Court for the District of Massachusetts Grants Summary Judgment to Sandoz
- Case
- Complex Litigation
- Pharmaceutical & Medical Device
- May 9, 2011
Firm Secures Defense Verdict for Novartis in First Bellwether Aredia/Zometa Jury Trial
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- October 22, 2010
Southern District of Florida Upholds Removal of a “Pure Bill of Discovery” in Novartis Elidel Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- November 26, 2006
NLJ Top Defense Win for Firm in First Trial of Hernia Repair Mesh Serial Litigation
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 10, 2004